Thyrotoxicosis in a Male Patient Associated with Excess Human Chorionic Gonadotropin Production by Germ Cell Tumor
Abstract
We report a case of a man with thyrotoxicosis due to excess production of human chorionic gonadotropin (hCG) by metastatic choriocarcinoma, followed by alterations of his thyroid function tests by nonthyroidal illness. All reported cases of thyrotoxicosis due to high hCG levels in male patients are reviewed. Patients with this syndrome usually have widespread choriocarcinoma and relatively few symptoms of thyrotoxicosis. Typically, if the patient survives the metastatic germ cell tumor, the thyrotoxicosis resolves as the hCG levels decrease after chemotherapy directed at the choriocarcinoma. Only rarely are specific antithyroid medications required. The hCG molecule directly stimulates the thyroid gland, and these patients appear to have in the serum a predominance of acidic variants of hCG with greater intrinsic thyroid-stimulating activity than the hCG secreted during a normal pregnancy. In general, these patients have a poor prognosis due to the usually widespread nature of the germ cell tumor at the time of diagnosis.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Patients with choriocarcinoma, including molar pregnancy and testicular cancer, may present with thyrotoxicosis because of the effect of tumor-derived hCG upon the TSH receptor.
“Patients with choriocarcinoma, including molar pregnancy and testicular cancer, may present with thyrotoxicosis because of the effect of tumor-derived hCG upon the TSH receptor (665-668).”
From 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis (2016) · cites this paper as [666]
The citation lists haven’t been fetched yet
References 29 · Cited by 20
- Authors
- Goodarzi, M. O., & Van Herle, A. J.
- Affiliations
- University of California, Los Angeles (US)
- ORCID
- Goodarzi, Mark O.
- Venue
- Thyroid
- Publisher
- SAGE Publications
- Published
- 2000-07
- Volume
- 10
- Issue
- 7
- Pages
- 611-619
- ISSN
- 1050-7256 (ISSN-L)
- 1557-9077
- OpenAlex
- W1983666201
- Cited by
- 20
- References
- 29
- Citations by year
- 2026: 1 · 2024: 5 · 2022: 1 · 2016: 1 · 2012: 1
- FWCI
- 0.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Thyroid (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Testicular diseases and treatments
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Gestational Trophoblastic Disease Studies
- Keywords
- thyrotoxicosis, human chorionic gonadotropin, choriocarcinoma, germ cell tumors, metastatic choriocarcinoma, male patients, low T3 syndrome, thyroid function tests, thyroid-stimulating activity, antithyroid drugs, chemotherapy, prognosis
- MeSH terms
- Adult, Antineoplastic Combined Chemotherapy Protocols, Choriocarcinoma, Chorionic Gonadotropin, Humans, Male, Neoplasm Metastasis, Orchiectomy, Testicular Neoplasms, Thyrotoxicosis, Fatal Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review